Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from Jinhai International Group Holdings Limited ( (HK:2225) ).
Jinhai Medical Technology Limited has announced a change in its company secretary, authorised representative, and process agent roles. Ms. Cheng Yuen has resigned from these positions, effective September 29, 2025, and Mr. Wong Man Yiu has been appointed to fill the vacancies. Mr. Wong, who previously served in similar roles within the company, brings extensive experience in company secretarial practices and regulatory requirements. This change is expected to maintain the company’s compliance and operational efficiency.
The most recent analyst rating on (HK:2225) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Jinhai International Group Holdings Limited stock, see the HK:2225 Stock Forecast page.
More about Jinhai International Group Holdings Limited
Jinhai Medical Technology Limited operates in the medical technology industry, focusing on providing advanced medical solutions and services. The company is incorporated in the Cayman Islands and is listed on the Hong Kong Stock Exchange.
Average Trading Volume: 12,232,770
Technical Sentiment Signal: Sell
Current Market Cap: HK$4.76B
Learn more about 2225 stock on TipRanks’ Stock Analysis page.